Aquilus Pharmaceuticals (Aquilus) is a biotech company focused on the treatment of neurodegenerative diseases, in particular Amyotrophic Lateral Sclerosis (ALS). Our dedicated team of researchers and scientists is committed to developing innovative therapies to address the unmet medical needs of patients suffering from these debilitating conditions. At Aquilus, we are driven by a passion to make a meaningful difference in the lives of patients and their families. Our relentless pursuit of scientific excellence and our patient-centric approach set us apart from others in the industry. We are dedicated to pushing the boundaries of scientific discovery to bring hope to those affected by neurodegenerative diseases. Join us in our mission to redefine the future of neurodegenerative treatments.